Developer docs
API playgroundTry for free, no card

Search company profiles

Latent

Full company profile

uuid0000amk

Namestring
Latent
Legal namestring
Latent
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Latent (DBA Latent Health) is a clinical AI company founded in 2022 by Sriram Somasundaram and Rishabh Jain, headquartered in San Francisco with a New York City office presence. The company develops the Enterprise Pharmacy Intelligence platform, powered by a Clinical Reasoning Engine that performs clinical knowledge work — reasoning through patient data, interpreting drug criteria, extracting evidence, and orchestrating workflows across EHRs, payer guidelines, and pharmacy operations. The platform consists of integrated modules covering prior authorization, appeals, denials, 340B eligibility auditing, prescription capture, and patient outreach/adherence, with native integration into Epic and Cerner EHRs.

The underlying technology stack combines large language models with proprietary components including CIPHER, a 1.5B-parameter encoder model for clinical de-identification that achieves 97.9% recall at roughly 1/1000th the inference cost of frontier LLMs. The platform is HIPAA- and SOC 2 Type 2-compliant with audit-defensible outputs that trace every action back to the patient chart. Training runs on Together AI's Instant GPU Clusters and deployment runs on Baseten infrastructure at five-nines availability.

Latent sells through a direct enterprise field sales motion to large U.S. health systems, targeting Chief Pharmacy Officers and pharmacy leadership. Revenue is generated via annual subscription licensing with quote-based pricing tied to health system size, deployed workflows, and volume metrics. The company serves 50+ health systems representing 50% of the top 20 U.S. health systems (Mayo Clinic, Mass General Brigham, NYU Langone, Mount Sinai, Yale New Haven, Ochsner, MetroHealth, Vanderbilt, among others) and processes 2 million+ patients annually. Forbes reported annualized revenue exceeding $20 million as of March 2026, following an $80 million Series A round co-led by Spark Capital and Transformation Capital that valued the company at approximately $600 million.

Short descriptiontext

Latent Health is a clinical AI company whose Enterprise Pharmacy Intelligence platform automates prior authorization, appeals, 340B, capture, and patient outreach for U.S. health system pharmacies, serving 50+ health systems including Mayo Clinic, Mount Sinai, and Mass General Brigham.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical AI platform, prior authorization automation, pharmacy intelligence software, medical language models, healthcare workflow automation
Industry3 codes
1Specialty Pharmacy & Complex Therapy Management Platforms
CodeHLACAKAGPrimaryYes
2PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
CodeHLAEAKALPrimaryNo
3Medication Pricing, Copay Assistance & Patient Financial Support Tools
CodeHLACAKANPrimaryNo
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare AI Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise SaaS Subscription
TypeSubscription Recurring
Description

Platform licensing to health systems for pharmacy intelligence. Pricing based on health system size, number of workflows deployed, and volume of prior authorizations/appeals processed. Typical contract structure includes multiple pharmacy workflows (prior authorization, appeals, 340B, capture, outreach) across specialty, infusion, and retail pharmacy operations.

forbes.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Enterprise health system licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing tailored to health system size, number of deployed workflows, and volume metrics. Contracts include implementation, training, and ongoing support.

forbes.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Latent sells an Enterprise Pharmacy Intelligence platform powered by a Clinical Reasoning Engine that automates clinical knowledge work for health system pharmacies. The platform handles prior authorization, appeals drafting, 340B eligibility auditing, prescription capture, patient outreach, and adherence monitoring. It is licensed to enterprise health systems via annual SaaS subscriptions and integrates natively with Epic and Cerner EHRs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Prior authorization review time reduced from 15-25 minutes to 4-5 minutes (75% faster)
+7 more records
Product overview1 text field

Latent offers the Enterprise Pharmacy Intelligence platform, a unified pharmacy operations platform powered by a Clinical Reasoning Engine that automates clinical knowledge work across the medication access lifecycle. The platform consists of integrated modules covering prior authorization, appeals, denials, 340B compliance, patient outreach/adherence, and financial capture. CIPHER, Latent's proprietary de-identification model, enables HIPAA-compliant processing of clinical documentation. The platform integrates natively with Epic and Cerner EHR systems and serves 50+ health systems across the United States.

Product and service2 records
1Enterprise Pharmacy Intelligence
CategoryCore Platform
Description

Latent's primary SaaS platform enabling 50+ leading health systems to grow pharmacy operations, serve more patients, and capture more value without adding headcount. Powers prior authorization, appeals, denials, 340B, capture, outreach, and adherence workflows across the full pharmacy stack.

2CIPHER
CategoryAI Sub-product
Description

A 1.5B-parameter encoder-based clinical de-identification model that redacts 18 categories of PHI identifiers from clinical documents. Achieves 97.9% recall at ~50ms per document with ~1000x lower inference cost than frontier LLMs, enabling HIPAA-compliant processing of clinical text.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierInfrastructure PartnerTypeTechnology or IntegrationAnnounced on2025-10-15
Description

Latent uses Together AI's Instant GPU Clusters for training. Achieved ~7x lower training cost, 97% clinical QA accuracy beating GPT-4/o3, and 2-3x faster experimentation enabling minutes-not-hours review cycles.

Strategic tierIntegration PartnerTypeTechnology or IntegrationAnnounced on2025-09-22
Description

Latent integrates with Epic EHR system. Vanderbilt University Medical Center implementation integrates with Epic and related operational tools.

Strategic tierInfrastructure PartnerTypeTechnology or IntegrationAnnounced on2025-09-10
Description

Latent's clinical search runs at five-nines availability with Baseten as deployment infrastructure.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cohere Health builds an AI-driven prior authorization and specialty care management platform for health plans and providers. Most directly comparable to Latent's Clinical Reasoning Engine and PA automation focus, competing for the same CPO and health-plan buying personas.

TypeDirect peer
Description

Anterior (formerly Cohort Health) is an AI-native prior authorization company automating clinical decisioning and medical necessity review for payers and providers. Overlaps directly with Latent on ePA, appeals drafting, and EHR-integrated workflows.

TypeDirect peer
Description

Myndshft provides real-time prior authorization and benefits verification automation for hospitals and specialty pharmacies using machine intelligence. Competes head-to-head with Latent on automating PA workflow at health system pharmacies.

TypeDirect peer
Description

Lean applies AI and process automation to prior authorization and revenue cycle workflows in healthcare providers. Smaller and earlier-stage than Latent but directly comparable in workflow automation approach and customer base.

TypeBroad incumbent
Description

Waystar is a large, established revenue cycle management platform with prior authorization and claims automation modules used by health systems. A scaled incumbent Latent competes against in the broader pharmacy and revenue cycle stack.

TypeBroad incumbent
Description

Surescripts operates the dominant U.S. electronic prescribing and benefits network, including real-time prescription benefit and electronic prior authorization tooling. A broad incumbent in the same ePA/eRx technology category, anchored to PBMs and EHRs.

TypeBroad incumbent
Description

Experian Health sells identity, eligibility, prior authorization, and patient access solutions to health systems and payers. Comparable as an incumbent PA/automation vendor with deeper payer integration than Latent currently has.

TypeBroad incumbent
Description

Phreesia automates patient intake, eligibility, and access workflows across health systems. An adjacent incumbent where patient access, insurance verification, and consumer-side workflow automation intersect with Latent's PA and outreach modules.

TypeBroad incumbent
Description

Olive AI has historically positioned as a healthcare AI automation vendor across revenue cycle and clinical workflows. A scaled broader player in healthcare AI workflow automation with overlapping but distinct coverage of pharmacy operations.

TypeEmerging player
Description

Macro Helix is a specialty 340B program management and compliance platform used by health systems and contract pharmacies. Overlaps narrowly with Latent's 340B audit module rather than its full PA stack.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Latent

Healthcare AI Softwarelatenthealth.com

Latent Health is a clinical AI company whose Enterprise Pharmacy Intelligence platform automates prior authorization, appeals, 340B, capture, and patient outreach for U.S. health system pharmacies, serving 50+ health systems including Mayo Clinic, Mount Sinai, and Mass General Brigham.

What Latent does

Latent (DBA Latent Health) is a clinical AI company founded in 2022 by Sriram Somasundaram and Rishabh Jain, headquartered in San Francisco with a New York City office presence. The company develops the Enterprise Pharmacy Intelligence platform, powered by a Clinical Reasoning Engine that performs clinical knowledge work — reasoning through patient data, interpreting drug criteria, extracting evidence, and orchestrating workflows across EHRs, payer guidelines, and pharmacy operations. The platform consists of integrated modules covering prior authorization, appeals, denials, 340B eligibility auditing, prescription capture, and patient outreach/adherence, with native integration into Epic and Cerner EHRs.

The underlying technology stack combines large language models with proprietary components including CIPHER, a 1.5B-parameter encoder model for clinical de-identification that achieves 97.9% recall at roughly 1/1000th the inference cost of frontier LLMs. The platform is HIPAA- and SOC 2 Type 2-compliant with audit-defensible outputs that trace every action back to the patient chart. Training runs on Together AI's Instant GPU Clusters and deployment runs on Baseten infrastructure at five-nines availability.

Latent sells through a direct enterprise field sales motion to large U.S. health systems, targeting Chief Pharmacy Officers and pharmacy leadership. Revenue is generated via annual subscription licensing with quote-based pricing tied to health system size, deployed workflows, and volume metrics. The company serves 50+ health systems representing 50% of the top 20 U.S. health systems (Mayo Clinic, Mass General Brigham, NYU Langone, Mount Sinai, Yale New Haven, Ochsner, MetroHealth, Vanderbilt, among others) and processes 2 million+ patients annually. Forbes reported annualized revenue exceeding $20 million as of March 2026, following an $80 million Series A round co-led by Spark Capital and Transformation Capital that valued the company at approximately $600 million.

Latent firmographics

Firmographics
Name
Latent
Legal name
Latent
Website
https://latenthealth.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
101–250 employees
Short description
Latent Health is a clinical AI company whose Enterprise Pharmacy Intelligence platform automates prior authorization, appeals, 340B, capture, and patient outreach for U.S. health system pharmacies, serving 50+ health systems including Mayo Clinic, Mount Sinai, and Mass General Brigham.
Ownership category
akta.pro rank

Latent industry classification

Industry
Product category
Healthcare AI Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
akta.pro secondary industries
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

Keywords

  • Clinical AI platform
  • Prior authorization automation
  • Pharmacy intelligence software
  • Medical language models
  • Healthcare workflow automation

Where Latent is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Latent business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Enterprise SaaS Subscription: Platform licensing to health systems for pharmacy intelligence. Pricing based on health system size, number of workflows deployed, and volume of prior authorizations/appeals processed. Typical contract structure includes multiple pharmacy workflows (prior authorization, appeals, 340B, capture, outreach) across specialty, infusion, and retail pharmacy operations.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise health system licensing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Latent product offering

Product offering

Core offering

Latent sells an Enterprise Pharmacy Intelligence platform powered by a Clinical Reasoning Engine that automates clinical knowledge work for health system pharmacies. The platform handles prior authorization, appeals drafting, 340B eligibility auditing, prescription capture, patient outreach, and adherence monitoring. It is licensed to enterprise health systems via annual SaaS subscriptions and integrates natively with Epic and Cerner EHRs.

Product overview

Latent offers the Enterprise Pharmacy Intelligence platform, a unified pharmacy operations platform powered by a Clinical Reasoning Engine that automates clinical knowledge work across the medication access lifecycle. The platform consists of integrated modules covering prior authorization, appeals, denials, 340B compliance, patient outreach/adherence, and financial capture. CIPHER, Latent's proprietary de-identification model, enables HIPAA-compliant processing of clinical documentation. The platform integrates natively with Epic and Cerner EHR systems and serves 50+ health systems across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Enterprise Pharmacy Intelligence Latent's primary SaaS platform enabling 50+ leading health systems to grow pharmacy operations, serve more patients, and capture more value without adding headcount. Powers prior authorization, appeals, denials, 340B, capture, outreach, and adherence workflows across the full pharmacy stack.
  • CIPHER A 1.5B-parameter encoder-based clinical de-identification model that redacts 18 categories of PHI identifiers from clinical documents. Achieves 97.9% recall at ~50ms per document with ~1000x lower inference cost than frontier LLMs, enabling HIPAA-compliant processing of clinical text.

Quantifiable outcome

  • Prior authorization review time reduced from 15-25 minutes to 4-5 minutes (75% faster)
  • +7 more outcomes

Companies that use Latent

Customer profile

Named customers14 records

Segments1 record

Ideal customer profiles1 record

Latent technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature7 records

Latent partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered infrastructure partner and integration partner.

  • Together AIinfrastructure partnerTechnology or Integration · 15 October 2025Latent uses Together AI's Instant GPU Clusters for training. Achieved ~7x lower training cost, 97% clinical QA accuracy beating GPT-4/o3, and 2-3x faster experimentation enabling minutes-not-hours review cycles.
  • Epicintegration partnerTechnology or Integration · 22 September 2025Latent integrates with Epic EHR system. Vanderbilt University Medical Center implementation integrates with Epic and related operational tools.
  • Baseteninfrastructure partnerTechnology or Integration · 10 September 2025Latent's clinical search runs at five-nines availability with Baseten as deployment infrastructure.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Latent competitors and assessment

Company assessment

Direct peers

  • Cohere Health: Cohere Health builds an AI-driven prior authorization and specialty care management platform for health plans and providers. Most directly comparable to Latent's Clinical Reasoning Engine and PA automation focus, competing for the same CPO and health-plan buying personas.
  • Anterior: Anterior (formerly Cohort Health) is an AI-native prior authorization company automating clinical decisioning and medical necessity review for payers and providers. Overlaps directly with Latent on ePA, appeals drafting, and EHR-integrated workflows.
  • Myndshft: Myndshft provides real-time prior authorization and benefits verification automation for hospitals and specialty pharmacies using machine intelligence. Competes head-to-head with Latent on automating PA workflow at health system pharmacies.
  • Lean Healthcare: Lean applies AI and process automation to prior authorization and revenue cycle workflows in healthcare providers. Smaller and earlier-stage than Latent but directly comparable in workflow automation approach and customer base.

Broad incumbents

  • Waystar: Waystar is a large, established revenue cycle management platform with prior authorization and claims automation modules used by health systems. A scaled incumbent Latent competes against in the broader pharmacy and revenue cycle stack.
  • Surescripts: Surescripts operates the dominant U.S. electronic prescribing and benefits network, including real-time prescription benefit and electronic prior authorization tooling. A broad incumbent in the same ePA/eRx technology category, anchored to PBMs and EHRs.
  • Experian Health: Experian Health sells identity, eligibility, prior authorization, and patient access solutions to health systems and payers. Comparable as an incumbent PA/automation vendor with deeper payer integration than Latent currently has.
  • Phreesia: Phreesia automates patient intake, eligibility, and access workflows across health systems. An adjacent incumbent where patient access, insurance verification, and consumer-side workflow automation intersect with Latent's PA and outreach modules.
  • Olive AI: Olive AI has historically positioned as a healthcare AI automation vendor across revenue cycle and clinical workflows. A scaled broader player in healthcare AI workflow automation with overlapping but distinct coverage of pharmacy operations.

Emerging players

  • Macro Helix: Macro Helix is a specialty 340B program management and compliance platform used by health systems and contract pharmacies. Overlaps narrowly with Latent's 340B audit module rather than its full PA stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Latent social profiles

Digital presence

Latent compliance and trust

Trust signal

Compliance2 records

Latent financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Latent leadership team

Management profile

Number of profiles

Profiles3 records

Latent funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Latent M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Latent

What does Latent do?

Latent sells an Enterprise Pharmacy Intelligence platform powered by a Clinical Reasoning Engine that automates clinical knowledge work for health system pharmacies. The platform handles prior authorization, appeals drafting, 340B eligibility auditing, prescription capture, patient outreach, and adherence monitoring. It is licensed to enterprise health systems via annual SaaS subscriptions and integrates natively with Epic and Cerner EHRs.

Is Latent a public or private company?

Latent is a private company. It is classified as venture growth investor backed and is currently operating.

When was Latent founded?

Latent was founded in 2022. It employs 101 to 250 people.

Where is Latent based?

Latent is headquartered in San Francisco, United States, in the North America region.

How does Latent make money?

One revenue line is on record: enterprise SaaS Subscription.

Who are Latent's main competitors?

Direct peers on record are Cohere Health, Anterior, Myndshft and Lean Healthcare. Broad incumbents are Waystar, Surescripts, Experian Health, Phreesia and Olive AI. Macro Helix is listed as an emerging player.

Does Latent have an API?

No public API is recorded for Latent.

What industry is Latent in?

Latent's product category is Healthcare AI Software. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BeckershospitalreviewCleveland Clinic, AdventHealth among 7 new Latent partners as pharmacy AI agents launchLatent, an enterprise pharmacy intelligence platform, launched autonomous AI agents for seven health systems including Cleveland Clinic and AdventHealth, expanding its footprint to 60 systems serving 70 million patients. The agents handle prior authorizations and compliance reviews for specialty drugs, with the company on pace to process over 5.8 million patient medication cases in 12 months.HcinnovationgroupLatent Unveils Autonomous Agents to Streamline Medication AccessLatent, an enterprise pharmacy intelligence platform, announced its platform is live in 60 U.S. health systems serving about 70 million patients. The company unveiled autonomous clinical agents to automate prior authorizations for high-demand therapies, on pace to process over 5.8 million medication cases in 12 months.Pulse 2.0Latent Expands AI Pharmacy Platform To 60 Health Systems Serving 70 Million PatientsLatent expanded its pharmacy intelligence platform to 60 U.S. health systems serving 70 million patients, adding autonomous clinical agents for medication access. The company is on pace to process over 5.8 million patient medication cases in 12 months, targeting GLP-1 and specialty therapies.BeckershospitalreviewPharmacy leaders are done waitingChief pharmacy officers at major U.S. health systems including Ochsner Health, Yale New Haven Health, and Mount Sinai Health System are deploying AI platforms to streamline pharmacy operations, with U.S. pharmaceutical expenditures growing nearly 13% in 2025 to over $915 billion and hospital drug expenses rising 13.6%. The technology, including enterprise pharmacy intelligence platforms such as Latent, is being used to automate prior authorization and other administrative workflows, enabling pharmacists to focus more on patient care rather than manual processes. The leaders report significant gains including reduced prior authorization turnaround times from weeks to days and doubled operational revenue without proportional hiring increases.TipranksAI-Driven Prior Authorization Gains Traction in Health System PharmaciesDiscussions at Becker's CPO Summit highlighted AI-driven prior authorization technology from Latent being deployed in health system pharmacies, with users like St. Luke's reducing its prior authorization queue from approximately 2,400 to 600 cases over five months. MetroHealth reportedly lowered turnaround times from 1–2 months to about two weeks, while Vanderbilt cleared 70 prior authorizations in under an hour. The article suggests these outcomes indicate growing traction for AI pharmacy automation solutions, positioning Latent for potential pricing power, customer expansion, and competitive advantage against other vendors in the revenue-cycle space.CB InsightsState of Digital Health Q1’26Digital health funding reached $7.4B in Q1'26, up from $5.9B, with mega-rounds capturing 60% of capital. M&A deals rose 47% to 56, led by Abbott's $23B Exact Sciences acquisition. Prior authorization mandates and AI drug discovery investments are expected to intensify consolidation in 2026.Pulse 2.0Latent: $80 Million Raised For Clinical AI Platform Accelerating Medication AccessLatent, a clinical AI company focused on accelerating patient access to medications, has raised $80 million in a Series A funding round co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator. The company's platform addresses administrative bottlenecks in healthcare that cause treatment delays, demonstrating measurable impact including a 30% reduction in treatment denials and partnerships with half of the top 20 U.S. health systems. Latent plans to use the funding to expand its health system partnerships and extend its AI platform beyond prior authorization to broader clinical workflow automation.TipranksLatent Showcases Ochsner Health Pharmacy Workflow Gains Through Automation PartnershipLatent, a technology company, is featured as a technology partner in a case study with Ochsner Health demonstrating workflow improvements in medication access and prior authorization processes using Latent's solutions. The case study reports significant performance gains including a 127% increase in prior authorization throughput, a 67% reduction in review time, and an 89% reduction in appeal review time. For investors, this suggests potential for expanded enterprise adoption and deeper integration into large health systems, which could support future revenue growth and competitive positioning.citybizLatent Raises $80M to Enable Faster Access to MedsLatent, a San Francisco-based clinical AI company founded in 2022, has raised $80 million in Series A funding co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst and Y Combinator. The company's AI platform automates prior authorization workflows by connecting electronic health records, payer guidelines, and pharmacy operations to streamline patient access to medications. Latent currently serves half of the top 20 U.S. health systems and enables over 2 million patients annually to access medications faster.VentureburnLatent Raises $80M to Expand AI Medication Access PlatformLatent, a San Francisco-based AI healthcare company, has raised $80 million in Series A funding led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator. The company's Clinical Reasoning Engine platform automates prior authorizations and clinical workflows, currently serving over two million patients annually across more than 45 health systems. The funding will be used to expand integrations with additional US hospitals, payers, and pharmacies and grow the team size.